Increased mortality risk associated with statins in the CORONADO study.
作者信息
Strandberg Timo E, Kivimäki Mika
机构信息
University of Helsinki and Helsinki University Hospital, Helsinki, Finland; University of Oulu, Centre for Life Course Health Research, Oulu, Finland.
University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
出版信息
Diabetes Metab. 2021 May;47(3):101250. doi: 10.1016/j.diabet.2021.101250. Epub 2021 Mar 17.
Abstract
摘要
相似文献
1
Increased mortality risk associated with statins in the CORONADO study.在CORONADO研究中，他汀类药物与死亡风险增加相关。
Diabetes Metab. 2021 May;47(3):101250. doi: 10.1016/j.diabet.2021.101250. Epub 2021 Mar 17.
2
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study.常规使用他汀类药物与 2 型糖尿病住院患者 COVID-19 相关死亡率的增加：来自 CORONADO 研究的结果。
Diabetes Metab. 2021 Mar;47(2):101202. doi: 10.1016/j.diabet.2020.10.001. Epub 2020 Oct 19.
3
Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia.他汀类药物治疗可能有助于预防因间质 SARS-CoV2 肺炎住院的患者发生急性肾损伤。
Nutr Metab Cardiovasc Dis. 2023 Jan;33(1):227-231. doi: 10.1016/j.numecd.2022.10.005. Epub 2022 Oct 18.
4
Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients.他汀类药物治疗对住院患者 COVID-19 感染相关死亡率的影响。
Eur Heart J Cardiovasc Pharmacother. 2022 Feb 16;8(2):157-164. doi: 10.1093/ehjcvp/pvaa128.
5
Statins and COVID-19: To Suspend or Not to Suspend? That is the Question!他汀类药物与新冠病毒病：停用还是不停用？这是个问题！
Arq Bras Cardiol. 2021 Jan;116(1):147-152. doi: 10.36660/abc.20200949.
6
Routine statins use is associated with less adverse outcome in patients above 70 years of age admitted to hospital with COVID-19.常规他汀类药物的使用与 COVID-19 住院的 70 岁以上患者的不良预后减少相关。
BMC Geriatr. 2023 Aug 7;23(1):473. doi: 10.1186/s12877-023-04183-8.
7
Statins and SARS-CoV-2 Infection: Results of a Population-Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces.他汀类药物与 SARS-CoV-2 感染：来自加拿大 2 个省份的 469749 名成年人的基于人群的前瞻性队列研究结果。
J Am Heart Assoc. 2021 Nov 2;10(21):e022330. doi: 10.1161/JAHA.121.022330. Epub 2021 Oct 23.
8
The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.他汀类药物使用与 COVID-19 患者不良结局之间的保护关联：系统评价和荟萃分析。
PLoS One. 2021 Jun 24;16(6):e0253576. doi: 10.1371/journal.pone.0253576. eCollection 2021.
9
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?他汀类药物和 PCSK9 抑制剂：它们在 2019 年冠状病毒病中的作用是什么？
Med Hypotheses. 2021 Jan;146:110452. doi: 10.1016/j.mehy.2020.110452. Epub 2020 Dec 9.
10
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy.在 COVID-19 大流行期间意大利三级转诊医院的研究：他汀类药物使用史对 COVID-19 患者临床结局的影响。
J Clin Lipidol. 2021 Jan-Feb;15(1):68-78. doi: 10.1016/j.jacl.2020.12.008. Epub 2020 Dec 29.
引用本文的文献
1
Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study.他汀类药物和/或肾素-血管紧张素-醛固酮系统调节治疗与因 COVID-19 住院的成年糖尿病患者死亡率的相关性：一项回顾性多中心欧洲研究。
Diabetes Metab Syndr. 2022 May;16(5):102484. doi: 10.1016/j.dsx.2022.102484. Epub 2022 Apr 11.
2
Statin use in patients with diabetes amid COVID-19 pandemic.2019冠状病毒病大流行期间糖尿病患者使用他汀类药物的情况。
Diabetes Metab. 2022 Jan;48(1):101298. doi: 10.1016/j.diabet.2021.101298. Epub 2021 Oct 25.
3
Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications.使用现有药物保护患有心血管疾病的老年患者免受 COVID-19 并发症的影响。
Eur Geriatr Med. 2021 Aug;12(4):725-739. doi: 10.1007/s41999-021-00504-5. Epub 2021 May 25.
本文引用的文献
1
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies.他汀类药物与 COVID-19 的临床结局：观察性研究的荟萃分析。
Diabetes Metab. 2021 Nov;47(6):101220. doi: 10.1016/j.diabet.2020.101220. Epub 2020 Dec 23.
2
Statin Use and In-Hospital Mortality in Patients With Diabetes Mellitus and COVID-19.他汀类药物在糖尿病合并 COVID-19 患者中的应用与院内死亡率。
J Am Heart Assoc. 2020 Dec 15;9(24):e018475. doi: 10.1161/JAHA.120.018475. Epub 2020 Oct 23.
3
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study.常规使用他汀类药物与 2 型糖尿病住院患者 COVID-19 相关死亡率的增加：来自 CORONADO 研究的结果。
Diabetes Metab. 2021 Mar;47(2):101202. doi: 10.1016/j.diabet.2020.10.001. Epub 2020 Oct 19.
4
Outcomes of Hospitalized COVID-19 Patients by Risk Factors: Results from a United States Hospital Claims Database.按风险因素划分的住院 COVID-19 患者的结局：来自美国医院理赔数据库的结果
J Health Econ Outcomes Res. 2020 Sep 29;7(2):165-174. doi: 10.36469/jheor.2020.17331. eCollection 2020.
5
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.英格兰 1 型和 2 型糖尿病患者 COVID-19 相关死亡率的风险因素：一项基于人群的队列研究。
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833. doi: 10.1016/S2213-8587(20)30271-0. Epub 2020 Aug 13.
6
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.住院期间使用他汀类药物与 COVID-19 患者的死亡率降低相关。
Cell Metab. 2020 Aug 4;32(2):176-187.e4. doi: 10.1016/j.cmet.2020.06.015. Epub 2020 Jun 24.
Zotero 插件